Module 19 – The Absence of Guidance as a Finding
Part of the Purus Lumina Device Care Education Programme
There is no guidance. That is not a neutral fact. It is a finding.
There is no published guidance from the MHRA, NHS England, NICE, the Home Office, or any licensed manufacturer on how a dry herb device used to administer a CBPM should be cleaned, maintained, or decommissioned. This is not an oversight. It is a documented gap — and a documented gap is a finding.
This module establishes that finding formally. It distinguishes between the absence of guidance and the absence of need. It documents what the absence means for patients, prescribers, and the institutions responsible for the pathway. And it records, as a matter of public record, that the gap has been identified, structured, and published.
What the absence means
In clinical and regulatory practice, the absence of guidance does not mean the matter is unimportant. It means no institution has yet taken responsibility for it. That distinction matters.
When a patient asks their prescriber how to clean their device, and the prescriber has no answer — not because the answer is unknown, but because no protocol exists — that is a failure of the system, not the patient. The absence of guidance creates a vacuum. Patients fill that vacuum with guesswork, internet searches, or nothing at all.
This module documents that vacuum as a formal finding: a gap in the regulatory and clinical framework that has real consequences for patient safety, device integrity, and clinical outcomes.
The difference between silence and permission
Regulatory silence is not regulatory permission. The fact that no guidance prohibits a particular cleaning method does not mean that method is safe, appropriate, or clinically endorsed. Equally, the absence of a mandated protocol does not mean device hygiene is optional.
A CBPM is a prescribed medicine. The device through which it is administered is a medical instrument in functional terms, regardless of its regulatory classification. The absence of formal guidance on its maintenance does not change the clinical reality of what it does or the risk profile of what accumulates within it.
Silence is not a standard. It is a gap.
Documenting the gap
The Purus Lumina Device Care Curriculum exists, in part, to document this gap formally and publicly. Each module in the Regulatory Series — Modules 17, 18, and 19 — contributes to a body of evidence that:
- Identifies what guidance exists and from whom
- Identifies what guidance does not exist and where it is absent
- Establishes that the absence has been noted, recorded, and published
- Provides a structured alternative in the absence of official standards
This curriculum is submittable to NICE, MHRA, NHS England, and the Home Office as a formal educational contribution. It is archivable in perpetuity. The absence of guidance, once documented, becomes part of the public record.
Why this matters for patients
Patients operating without guidance are not operating freely — they are operating without support. The absence of a cleaning protocol does not protect them. It exposes them to risk they cannot quantify, from a source they cannot identify, with no institutional recourse if something goes wrong.
A patient who develops a respiratory complication linked to device contamination has no regulatory framework to reference. No standard was breached, because no standard existed. That is not a legal protection for the patient. It is a structural failure that the absence of guidance enables.
Documenting the gap is the first step toward closing it.
The institutional responsibility
The absence of guidance is not solely a patient issue. It is an institutional one. Prescribers, clinics, and regulators who operate in the prescribed CBPM space without addressing device hygiene are not operating in a neutral position — they are operating in a gap they have not yet chosen to fill.
This curriculum does not assign blame. It assigns responsibility — to the institutions best placed to act, and to the patients who must act in their absence.
In plain terms
No one has told you how to clean your device because no institution has written the standard. That is not your fault. It is a gap in the pathway — one that this curriculum has now documented, structured, and published.
The gap is real. The consequences are real. The documentation is now part of the record. What the institutions responsible for the pathway do with it is their decision. That it exists is no longer deniable.
Notice of Intent
This curriculum has been submitted to the MHRA, Home Office, NHS England, NICE, the Care Quality Commission, relevant parliamentary and clinical bodies, and device manufacturers operating within the UK prescribed CBPM pathway, as a formal educational contribution to a documented gap in patient care. It is published in perpetuity as a matter of public record. Purus Lumina reserves all rights to the curriculum structure, content, and methodology.
Get the Solution
The Purus Lumina Device Purification Solution — purpose-formulated for dry herb devices used in prescribed CBPM administration. 99.9% pharmaceutical-grade. UK-made. Available in 250ml, 500ml, and 1L.
Get the Device Purification Solution →
Continue to Module 20 – What Comes Next →
← Back to Module 18 – The Evidence Base
← Return to the Device Care Education hub
Module 19 is part of the Purus Lumina Device Care Curriculum — the world's first documented device care education programme for patients prescribed botanical medicine. Published as a matter of public record. Preserved in perpetuity.
This module was published on 4 July 2026 and exists in perpetuity as part of the Purus Lumina Device Care Curriculum — the world's first documented device care education programme for patients prescribed botanical medicine. It will not be removed.
Glenn Hailes · Director · Purus Lumina Ltd · 3rd Floor, 86–90 Paul Street · London EC2A 4NE · United Kingdom · Registered in England and Wales